Study of Factors Linked to Low Blood Eosinophil Levels and Their Recovery After Severe COPD Flare-Ups

What this Trial Is About

Researchers are investigating factors linked to low blood eosinophil counts eosinopenia in patients hospitalized with severe flare-ups of chronic obstructive pulmonary disease COPD. They aim to identify what influences eosinopenia on admission and to find out how long it takes for eosinophil levels to return to normal after such severe episodes. This observational study focuses on understanding these patterns to help guide treatment decisions, particularly regarding inhaled corticosteroids ICS. The study observes patients admitted with severe COPD exacerbations and measures their blood eosinophil counts over time. Participants are grouped based on whether their eosinophil counts are low or normal at admission. Blood samples and clinical data are collected at admission and repeatedly over six weeks to monitor recovery of eosinophil counts to a stable baseline. Researchers examine various clinical and physiological factors related to eosinopenia and its recovery. During the study, participants undergo blood tests, clinical assessments, and monitoring of their health status at admission, and at 1, 2, 3, 4, and 6 weeks afterward. The main outcomes include identifying factors associated with low eosinophil counts at admission and measuring the time needed for eosinophil levels to recover. Secondary analyses look at changes in immune markers, comparison with past exacerbations, and the influence of new exacerbations on eosinophil recovery. The total participation duration varies per participant but includes follow-up through six weeks post-admission.

Eosinopenia in Severe COPD Exacerbation